Paul Hastings LLP advised Jasper Therapeutics, Inc., while DLA Piper advised the underwriters. Jasper Therapeutics, Inc. (Nasdaq: JSPR), a clinical-stage biotechnology company focused on developing novel...
Jasper Therapeutics’ $50 Million Common Stock Offering
Philip Morris International Inc.’s $6 Billion Debt Offering
Simpson Thacher & Bartlett represented the underwriters in connection with a registered public offering by Philip Morris International Inc., assisted by DLA Piper. Philip Morris International...